MedPath
HSA Approval

Gabapentin Sandoz Capsules 400mg

SIN13678P

Gabapentin Sandoz Capsules 400mg

Gabapentin Sandoz Capsules 400mg

July 20, 2009

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

N03AX12

xn 03 ax 12

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Sandoz Private Limited, Kalwe Site

Active Ingredients

Gabapentin

400mg

Gabapentin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Gabapentin Sandoz Capsules 400mg - HSA Approval | MedPath